Get started
Author

Daniel Lee

ORCID: 0009-0008-0478-6473
Observed ORCID: 0009-0008-0478-6473
OpenAlex ID: A5048538305
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era.
2024 · Daniel Lee, Alexander Yang, et al. · Journal of Clinical Oncology · 2
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma
2025 · Elizabeth A. Mendes, Aanandi Munshi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma
2025 · Tyler J. Aprati, Chi-Ping Day, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Abstract A004: Altered RNA splicing drives pancreatic cancer by mimicking chromosome deletions
2025 · Natasha Pinto Medici, Diana Martinez-Saucedo, et al. · Cancer Research
Transcriptome analysis identifies CCDC86 as a new potential Head and Neck Squamous Cell Carcinoma biomarker
2024 · Daniel Lee, Jules Gouron, et al. · Dentistry Review
SH2B3 mutation as a potential resistance mechanism to oncolytic virus therapy.
2024 · Philippos Apolinario Costa, Jeffrey Joseph Ishizuka, et al. · Journal of Clinical Oncology
Subsets of interferon signaling and response to immune checkpoint blockade.
2023 · Daniel Lee, Brooke Horowitch, et al. · Journal of Clinical Oncology
PDF
Works count: 8
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type